Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)

NCT03624946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Zika Virus Infection
Zika Virus Disease

Interventions

BIOLOGICAL: Zika Virus Immune Globulin (ZIKV-IG)
OTHER: Placebo

Sponsor

Emergent BioSolutions